Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2541-2560 of 2,731 trials

A Study Of CP-690,550 In Stable Kidney Transplant Patients

NCT01710033

This was a Phase 1 dose escalation study to evaluate the safety, tolerability and pharmacokinetics of 28-day treatment of CP-690,550 in stable renal allograft recipients. In Stage 1, ascending doses of CP-690,550 were to be administered sequentially to 3-4 cohorts of subjects. After Stage 1, one dose level was to be selected for dosing in an expanded cohort in Stage 2.

Kidney Transplant

Pfizer28 participantsStarted Sep 2003

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +8 more locations

TERMINATEDPhase 2< 1 mile

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

NCT01013480

Study 22001, "A Double-Blind, Placebo-Controlled, Flexible-Dose Evaluation of the Efficacy, Safety, and Tolerability of STX209 in the Treatment of Irritability in Subjects with Fragile X Syndrome" currently is evaluating the efficacy of STX209 (R-baclofen) for management of typical problem behaviors, such as irritability and aggression, in subjects with FXS. This study (22002) will enter subjects who complete Study 22001 into a long-term, open-label study.The open-label extension protocol will provide necessary data on the long-term safety and tolerability of STX209 among subjects with FXS who receive treatment under conditions more closely reflective of their general medical care.

Fragile X Syndrome

Seaside Therapeutics, Inc.45 participantsStarted Nov 2009

Los Angeles, California, United States • Sacramento, California, United States • Chicago, Illinois, United States +6 more locations

A Study Of CP-690,550 In Stable Kidney Transplant Patients

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

Rheumatoid Arthritis Trials in Other Cities

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

An Implantable Spinal Cord Stimulation Pain Management System

Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

A Drug-Drug Interaction Study of Losartan and PA21

FS VH S/D 500 S-apr in Vascular Surgery

GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)

A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis

A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)

Other Conditions in Los Angeles